ES2061739T3 - 5-(amino-sustituida)-8-(fenil o fenil-sustituidas)-3h,6h-1,4,5a,8a-tetraazaacenaftilen-3-onas, que son utiles como agentes para el tratamiento de trastornos del comportamiento cognitivo y neural asociado con el mismo en animales mamiferos. - Google Patents

5-(amino-sustituida)-8-(fenil o fenil-sustituidas)-3h,6h-1,4,5a,8a-tetraazaacenaftilen-3-onas, que son utiles como agentes para el tratamiento de trastornos del comportamiento cognitivo y neural asociado con el mismo en animales mamiferos.

Info

Publication number
ES2061739T3
ES2061739T3 ES89100657T ES89100657T ES2061739T3 ES 2061739 T3 ES2061739 T3 ES 2061739T3 ES 89100657 T ES89100657 T ES 89100657T ES 89100657 T ES89100657 T ES 89100657T ES 2061739 T3 ES2061739 T3 ES 2061739T3
Authority
ES
Spain
Prior art keywords
substituted
treatment
amino
useful
tetraazaacenaftilen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89100657T
Other languages
English (en)
Inventor
Joseph William Epstein
Jeremy Ian Levin
Shin Shyong Tseng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2061739T3 publication Critical patent/ES2061739T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/16—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

ESTE DESCUBRIMIENTO DESCRIBE UN NUEVO 5 - (SUSTITUIDO AMINO) - 8 (SUSTITUIDO FENIL) - 3H, 6H - 1, 4, 5A, 8A - TETRAAZAACENAFTELIN - 3 - ONAS UTILES PARA EL TRATAMIENTO DE DESORDENES DE CONDUCTAS NEURALES CONOCIDOS Y RELATADOS EN MAMIFEROS.
ES89100657T 1988-02-22 1989-01-16 5-(amino-sustituida)-8-(fenil o fenil-sustituidas)-3h,6h-1,4,5a,8a-tetraazaacenaftilen-3-onas, que son utiles como agentes para el tratamiento de trastornos del comportamiento cognitivo y neural asociado con el mismo en animales mamiferos. Expired - Lifetime ES2061739T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15844888A 1988-02-22 1988-02-22

Publications (1)

Publication Number Publication Date
ES2061739T3 true ES2061739T3 (es) 1994-12-16

Family

ID=22568168

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89100657T Expired - Lifetime ES2061739T3 (es) 1988-02-22 1989-01-16 5-(amino-sustituida)-8-(fenil o fenil-sustituidas)-3h,6h-1,4,5a,8a-tetraazaacenaftilen-3-onas, que son utiles como agentes para el tratamiento de trastornos del comportamiento cognitivo y neural asociado con el mismo en animales mamiferos.

Country Status (23)

Country Link
EP (1) EP0329940B1 (es)
JP (1) JP2641556B2 (es)
KR (1) KR970009226B1 (es)
AR (1) AR247211A1 (es)
AT (1) ATE99686T1 (es)
AU (1) AU611769B2 (es)
CA (1) CA1329594C (es)
CZ (1) CZ284273B6 (es)
DD (1) DD283624A5 (es)
DE (1) DE68911951T2 (es)
DK (1) DK172397B1 (es)
ES (1) ES2061739T3 (es)
FI (1) FI89922C (es)
HU (1) HU203554B (es)
IE (1) IE64147B1 (es)
IL (1) IL88974A (es)
NO (1) NO169589C (es)
NZ (1) NZ228009A (es)
PH (1) PH26358A (es)
PL (1) PL158865B1 (es)
PT (1) PT89766B (es)
SK (1) SK105589A3 (es)
ZA (1) ZA891310B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013737A (en) * 1988-02-22 1991-05-07 American Cyanamid Company 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones
EP0562236A1 (en) * 1992-03-26 1993-09-29 American Cyanamid Company Process for the synthesis of 5-[(substituted)-amino]-8-[phenyl or substiutued-phenyl]-3H, 6H-1, 4, 5A, 8A-tetraazaacephthylen-3-ones
EP0957918A1 (en) * 1996-12-19 1999-11-24 American Cyanamid Company Method of treating or inhibiting neutropenia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4236005A (en) * 1979-07-02 1980-11-25 American Cyanamid Company Imidazo[1,5-a]pyrimidines
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US4576943A (en) * 1984-10-09 1986-03-18 American Cyanamid Company Pyrazolo[1,5-a]pyrimidines
EP0264773A1 (en) * 1986-10-16 1988-04-27 American Cyanamid Company 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidines

Also Published As

Publication number Publication date
ZA891310B (en) 1989-11-29
PT89766B (pt) 1994-03-31
EP0329940B1 (en) 1994-01-05
HU203554B (en) 1991-08-28
DK79589D0 (da) 1989-02-21
JP2641556B2 (ja) 1997-08-13
IL88974A (en) 1993-03-15
CA1329594C (en) 1994-05-17
JPH01249774A (ja) 1989-10-05
KR970009226B1 (en) 1997-06-09
CZ105589A3 (cs) 1998-07-15
FI890826A (fi) 1989-08-23
NO169589B (no) 1992-04-06
PL158865B1 (pl) 1992-10-30
DE68911951T2 (de) 1994-06-01
KR890013022A (ko) 1989-09-20
DK172397B1 (da) 1998-05-18
AR247211A1 (es) 1994-11-30
PT89766A (pt) 1989-10-04
EP0329940A1 (en) 1989-08-30
FI890826A0 (fi) 1989-02-21
IE64147B1 (en) 1995-07-12
NZ228009A (en) 1991-09-25
FI89922B (fi) 1993-08-31
IE890543L (en) 1989-08-22
IL88974A0 (en) 1989-08-15
DE68911951D1 (de) 1994-02-17
SK279319B6 (sk) 1998-09-09
AU611769B2 (en) 1991-06-20
DK79589A (da) 1989-08-23
PH26358A (en) 1992-04-29
AU3017289A (en) 1989-08-24
PL277837A1 (en) 1989-11-13
FI89922C (fi) 1993-12-10
SK105589A3 (en) 1998-09-09
CZ284273B6 (cs) 1998-10-14
NO890724D0 (no) 1989-02-21
HUT51626A (en) 1990-05-28
NO890724L (no) 1989-08-23
DD283624A5 (de) 1990-10-17
ATE99686T1 (de) 1994-01-15
NO169589C (no) 1992-07-15

Similar Documents

Publication Publication Date Title
ES2177601T3 (es) Ranolazina y pepeerazinas relacionadas para uso en el tratamiento de estados de choque. .
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
PT1132403E (pt) Peptidos inibidores de tgf g beta1
ES2149888T3 (es) 3-(3,4-dioxifenil)-pirrolidinas como inhibidores de la fosfodiesterasa de tipo iv para el tratamiento de enfermedades inflamatorias.
PT901374E (pt) Tetra-hidropteridinas e piridilpiperazinas para o tratamento de disturbios neurologicos
CO4700426A1 (es) Ligandos especificos del neuropeptido y1
ES493812A0 (es) Procedimiento para el tratamiento de azufre insoluble.
ES2164088T3 (es) Antagonistas de la sustancia p para el tratamiento de la emesis.
ATE254476T1 (de) 88kda tumorgener wachstumsfaktor und antagonisten
ES2063747T3 (es) Nuevos benzotiofenos que tienen actividad antialergica, asi como nuevos benzotiofenos y otros benzotiofenos seleccionados que tienen actividad para el tratamiento del sindrome de malestar respiratorio agudo.
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
ES2100689T3 (es) Asociacion sinergizante que tiene un efecto antagonista de los receptores nk1 y nk2.
ES2061739T3 (es) 5-(amino-sustituida)-8-(fenil o fenil-sustituidas)-3h,6h-1,4,5a,8a-tetraazaacenaftilen-3-onas, que son utiles como agentes para el tratamiento de trastornos del comportamiento cognitivo y neural asociado con el mismo en animales mamiferos.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
ES2063521T3 (es) Mezcla de sustancias con accion terapeutica constituida por compuestos de glutation y antociano.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
GT199500039BA (es) Compuestos ariltios
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
DE60036638D1 (de) Verwendung von colostrinin, dessen peptidbestandteile und deren analoga zur förderung der neuronalen zelldifferenzierung
BR8001832A (pt) Agente para o tratamento de couros e calcados, com brilho proprio
DE69425345T2 (de) Anwendung von Selegilin in Tiermedizin
MX9203339A (es) Tratamiento de enfermedad inflamatoria articular.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 329940

Country of ref document: ES